The Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass (TRICC) study: Design and rationale☆
To access this article, please choose from the options below
☆ Supported primarily by grant FD-R-1971-01 from the US Food and Drug Administration to Michael A. Portman, and NIH grants M01RR00037 and M01RR001271. Triostat provided by King Pharmaceuticals.
PII: S0002-8703(04)00155-3
doi:10.1016/j.ahj.2004.03.029
© 2004 Elsevier Inc. All rights reserved.
